Prospective evaluation of sexual health in breast cancer women during the first year of adjuvant hormonal treatment using a cancer patient's dedicated questionnaire: A glaring gap of communication between health professionals and patients.
Adjuvant hormonal treatment
Breast cancer
EORTC SHQ-C22
Sexual quality of life
Journal
Breast cancer research and treatment
ISSN: 1573-7217
Titre abrégé: Breast Cancer Res Treat
Pays: Netherlands
ID NLM: 8111104
Informations de publication
Date de publication:
Apr 2021
Apr 2021
Historique:
received:
16
11
2020
accepted:
15
12
2020
pubmed:
17
1
2021
medline:
24
6
2021
entrez:
16
1
2021
Statut:
ppublish
Résumé
Sexual quality of life (QoL) is affected during and after breast cancer (BC) treatment and is not specifically evaluated with the general health-related quality-of-life questionnaires EORTC QLQ-C30 or QLQ-BR23. A specific questionnaire, the EORTC SHQ-C22, including physical, psychological, and social aspects of sexuality, was recently developed to address this issue in cancer patients. A prospective bicentric study was conducted to evaluate the sexual QoL of women with BC during the first year of adjuvant hormonal treatment. A total of 106 women completed the 3 questionnaires at baseline and 92 of them, at 12 months. At baseline, we showed low sexual satisfaction and importance given to sexual activity and a very low communication with healthcare professionals about this issue. Twelve months later, the importance given to sexuality had increased. While the communication with professionals had improved, it remained at a very low level. We were unable to identify specific clinical factors (chemotherapy, menopausal status, type of surgery or radiotherapy) that would negatively affect the global sexual well-being in BC patients. The analysis of sexual QoL of BC patients during the first year of hormonal treatment with a recently developed, cancer-dedicated, standardized tool pointed out the need for deeper communication between professionals and patients regarding sexual issues to fill the current gap in care of cancer patients and help patients with adequate intervention and support.
Identifiants
pubmed: 33452553
doi: 10.1007/s10549-020-06062-x
pii: 10.1007/s10549-020-06062-x
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
705-713Subventions
Organisme : none
ID : -
Organisme : none
Références
Bray F, Ferlay J, Soerjomataram I et al (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394–424. https://doi.org/10.3322/caac.21492
doi: 10.3322/caac.21492
pubmed: 30207593
pmcid: 30207593
Burstein HJ, Lacchetti C, Anderson H et al (2019) Adjuvant endocrine therapy for women with hormone receptor-positive breast cancer: ASCO clinical practice guideline focused update. J Clin Oncol 37:423–438. https://doi.org/10.1200/JCO.18.01160
doi: 10.1200/JCO.18.01160
pubmed: 30452337
Allemani C, Matsuda T, Di Carlo V et al (2018) Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. The Lancet 391:1023–1075. https://doi.org/10.1016/S0140-6736(17)33326-3
doi: 10.1016/S0140-6736(17)33326-3
Ganz PA, Rowland JH, Desmond K et al (1998) Life after breast cancer: understanding women’s health-related quality of life and sexual functioning. J Clin Oncol 16:501–514. https://doi.org/10.1200/JCO.1998.16.2.501
doi: 10.1200/JCO.1998.16.2.501
pubmed: 9469334
Runowicz CD, Leach CR, Henry NL et al (2016) American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline. J Clin Oncol 34:611–635. https://doi.org/10.1200/JCO.2015.64.3809
doi: 10.1200/JCO.2015.64.3809
pubmed: 26644543
Aaronson NK, Ahmedzai S, Bergman B et al (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85:365–376. https://doi.org/10.1093/jnci/85.5.365
doi: 10.1093/jnci/85.5.365
pubmed: 8433390
Sprangers MA, Groenvold M, Arraras JI et al (1996) The European Organization for Research and Treatment of Cancer breast cancer-specific quality-of-life questionnaire module: first results from a three-country field study. J Clin Oncol 14:2756–2768. https://doi.org/10.1200/JCO.1996.14.10.2756
doi: 10.1200/JCO.1996.14.10.2756
pubmed: 8874337
Ananth H, Jones L, King M, Tookman A (2003) The impact of cancer on sexual function: a controlled study. Palliat Med 17:202–205. https://doi.org/10.1191/0269216303pm759oa
doi: 10.1191/0269216303pm759oa
pubmed: 12701852
Krychman ML, Pereira L, Carter J, Amsterdam A (2006) Sexual oncology: sexual health issues in women with cancer. Oncology 71:18–25. https://doi.org/10.1159/000100521
doi: 10.1159/000100521
pubmed: 17347586
Pup LD, Villa P, Amar ID et al (2019) Approach to sexual dysfunction in women with cancer. International Journal of Gynecologic Cancer. https://doi.org/10.1136/ijgc-2018-000096
doi: 10.1136/ijgc-2018-000096
Frechette D, Paquet L, Verma S et al (2013) The impact of endocrine therapy on sexual dysfunction in postmenopausal women with early stage breast cancer: encouraging results from a prospective study. Breast Cancer Res Treat 141:111–117. https://doi.org/10.1007/s10549-013-2659-y
doi: 10.1007/s10549-013-2659-y
pubmed: 23942873
Ribi K, Luo W, Walley BA et al (2020) Treatment-induced symptoms, depression and age as predictors of sexual problems in premenopausal women with early breast cancer receiving adjuvant endocrine therapy. Breast Cancer Res Treat 181:347–359. https://doi.org/10.1007/s10549-020-05622-5
doi: 10.1007/s10549-020-05622-5
pubmed: 32274665
Oberguggenberger AS, Nagele E, Inwald EC et al (2018) Phase 1–3 of the cross-cultural development of an EORTC questionnaire for the assessment of sexual health in cancer patients: the EORTC SHQ-22. Cancer Med 7:635–645. https://doi.org/10.1002/cam4.1338
doi: 10.1002/cam4.1338
pubmed: 29436144
pmcid: 5852351
9781405146500: Sample Size Tables for Clinical Studies – AbeBooks – Machin, David; Campbell, Michael J.; Tan, Say–Beng; Tan, Sze–Huey: 1405146508. https://www.abebooks.fr/9781405146500/Sample-Size-Tables-Clinical-Studies-1405146508/plp . Accessed 2 Nov 2020.
Cheng KKF, Lim YTE, Koh ZM, Tam WWS (2017) Home-based multidimensional survivorship programmes for breast cancer survivors. Cochrane Database Syst Rev 8:CD011152. https://doi.org/10.1002/14651858.CD011152.pub2
doi: 10.1002/14651858.CD011152.pub2
pubmed: 28836379
Ganz PA, Kwan L, Stanton AL et al (2004) Quality of life at the end of primary treatment of breast cancer: first results from the moving beyond cancer randomized trial. J Natl Cancer Inst 96:376–387. https://doi.org/10.1093/jnci/djh060
doi: 10.1093/jnci/djh060
pubmed: 14996859
Den Oudsten BL, Van Heck GL, Van der Steeg AFW et al (2010) Clinical factors are not the best predictors of quality of sexual life and sexual functioning in women with early stage breast cancer. Psychooncology 19:646–656. https://doi.org/10.1002/pon.1610
doi: 10.1002/pon.1610
Yang EJ, Kim S-W, Heo C-Y, Lim J-Y (2011) Longitudinal changes in sexual problems related to cancer treatment in Korean breast cancer survivors: a prospective cohort study. Support Care Cancer 19:909–918. https://doi.org/10.1007/s00520-010-0885-y
doi: 10.1007/s00520-010-0885-y
pubmed: 20419495
Aerts L, Christiaens MR, Enzlin P et al (2014) Sexual functioning in women after mastectomy versus breast conserving therapy for early-stage breast cancer: a prospective controlled study. Breast 23:629–636. https://doi.org/10.1016/j.breast.2014.06.012
doi: 10.1016/j.breast.2014.06.012
pubmed: 25082211
Rosenberg SM, Tamimi RM, Gelber S et al (2014) Treatment-related amenorrhea and sexual functioning in young breast cancer survivors: sexual function and breast cancer. Cancer 120:2264–2271. https://doi.org/10.1002/cncr.28738
doi: 10.1002/cncr.28738
pubmed: 24891236
pmcid: 4116329
Kowalczyk R, Nowosielski K, Cedrych I et al (2019) Factors affecting sexual function and body image of early-stage breast cancer survivors in poland: a short-term observation. Clinical Breast Cancer 19:e30–e39. https://doi.org/10.1016/j.clbc.2018.09.006
doi: 10.1016/j.clbc.2018.09.006
pubmed: 30385228
Bajos N, Bozon M, Beltzer N, l’équipe CSF, (2008) Sexualité, prévention et rapports sociaux de sexe au fil de la vie. Médecine/sciences 24:24–32. https://doi.org/10.1051/medsci/2008242s24
doi: 10.1051/medsci/2008242s24
Marsh S, Borges VF, Coons HL, Afghahi A (2020) Sexual health after a breast cancer diagnosis in young women: clinical implications for patients and providers. Breast Cancer Res Treat 184:655–663. https://doi.org/10.1007/s10549-020-05880-3
doi: 10.1007/s10549-020-05880-3
pubmed: 32968951
Webber K, Mok K, Bennett B et al (2011) If I am in the mood, I enjoy it: an exploration of cancer-related fatigue and sexual functioning in women with breast cancer. Oncologist 16:1333–1344. https://doi.org/10.1634/theoncologist.2011-0100
doi: 10.1634/theoncologist.2011-0100
pubmed: 21835897
pmcid: 3228173
Carter J, Lacchetti C, Andersen BL et al (2018) Interventions to address sexual problems in people with cancer: american society of clinical oncology clinical practice guideline adaptation of cancer care ontario guideline. J Clin Oncol 36:492–511. https://doi.org/10.1200/JCO.2017.75.8995
doi: 10.1200/JCO.2017.75.8995
pubmed: 29227723